What is the recommended dose of Amoxicillin-Clavulanate (Amox-Clav) for a patient with severe impaired renal function, specifically a creatinine clearance (CrCl) of 20?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin-Clavulanate Dosing for CrCl 20 mL/min

For a patient with CrCl 20 mL/min, administer amoxicillin-clavulanate 500 mg/125 mg every 12 hours for less severe infections, or 500 mg/125 mg every 12 hours for more severe infections (not the 875 mg dose). 1

FDA-Approved Dosing Recommendations

The FDA label provides clear guidance for renal impairment 1:

  • CrCl 10-30 mL/min (which includes CrCl 20): 500 mg/125 mg or 250 mg/125 mg every 12 hours, depending on infection severity 1
  • The 875 mg/125 mg dose is contraindicated when GFR <30 mL/min 1
  • CrCl <10 mL/min: 500 mg/125 mg or 250 mg/125 mg every 24 hours 1

Practical Dosing Algorithm

For CrCl 20 mL/min, select dose based on infection severity:

  • Severe infections (pneumonia, complicated UTI, severe skin/soft tissue): 500 mg/125 mg every 12 hours 1
  • Less severe infections (uncomplicated UTI, mild skin infections): 250 mg/125 mg every 12 hours 1

Critical Pharmacokinetic Considerations

The differential clearance of amoxicillin versus clavulanate creates a dosing challenge in renal impairment. 2 Research demonstrates that amoxicillin clearance decreases more dramatically than clavulanate clearance as kidney function declines 2. At CrCl 10-35 mL/min, the ratio of amoxicillin to clavulanate exposure increases to 11.9 (compared to 4.9 at normal renal function), meaning amoxicillin accumulates disproportionately 2.

Standard dose reductions may lead to subtherapeutic amoxicillin concentrations, particularly for less susceptible pathogens. 3 A 2022 study showed that recommended dose adjustments resulted in only 38-62% probability of target attainment for MIC 8 mg/L at CrCl 20-30 mL/min, compared to 100% with standard dosing 3. However, for highly susceptible organisms (MIC ≤2 mg/L), reduced doses maintain >90% target attainment 3.

Common Pitfalls to Avoid

  • Do not use two 250 mg/125 mg tablets to replace one 500 mg/125 mg tablet - they contain different amounts of clavulanate and are not interchangeable 1
  • Do not use the 875 mg/125 mg formulation at any dosing interval when CrCl <30 mL/min 1
  • Avoid underdosing for serious infections - the standard dose reductions may be insufficient for pathogens with MIC >2 mg/L, particularly in hospitalized patients 3

Hemodialysis Considerations

If the patient progresses to hemodialysis 1:

  • Administer 500 mg/125 mg or 250 mg/125 mg every 24 hours (based on severity)
  • Give an additional dose both during and at the end of dialysis 1
  • Hemodialysis removes amoxicillin with a half-life of 2.3 hours during dialysis 4

Monitoring Recommendations

For CrCl 20 mL/min, monitor for 5, 2:

  • Clinical response within 48-72 hours
  • Adverse effects related to drug accumulation (particularly amoxicillin), including rash, GI disturbances, and CNS effects
  • Renal function changes that may necessitate further dose adjustment 5

Related Questions

What is the recommended dosing of amoxicillin for a patient with impaired renal function?
What is the recommended dosage of Amoxiclav (amoxicillin-clavulanate) for a patient with chronic kidney disease (CKD) and suspected bacterial lower respiratory tract infection?
What is the recommended intravenous dosage of amoxicillin (amoxicillin-clavulanic acid) for a patient with impaired renal function and a history of allergy to penicillins?
What is the appropriate amoxicillin dosage for an adult with a GFR of 35 mL/min?
What is the recommended dosing of Amoxiclav (amoxicillin-clavulanate) for patients with impaired renal function?
What can be trialed for a patient with schizoaffective bipolar type, currently taking Invega (paliperidone) injection and aripiprazole 10 mg, with a history of hyperprolactinemia and galactorrhea, who is experiencing insomnia that was not resolved with doxepin?
What is the likely diagnosis for a patient with a degenerative lumbar spine condition at the L5-S1 level, as indicated by an MRI (Magnetic Resonance Imaging) scan showing a diffuse disc bulge and a small posterior central extruded component?
What is the recommended treatment for a pediatric patient with a vaginal yeast infection?
What are the management options for a patient presenting with knee pain?
What is the interpretation and management of arterial study results showing monophasic waveform in both posterior tibial artery (PTA) and right anterior tibial artery (ATA), indicating severe peripheral artery disease (PAD) with possible hemodynamically significant stenosis?
What is the initial approach to managing early interstitial lung disease (ILD), particularly in patients with idiopathic pulmonary fibrosis (IPF)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.